Home Cart Sign in  
Chemical Structure| 153559-49-0 Chemical Structure| 153559-49-0

Structure of Bexarotene
CAS No.: 153559-49-0

Chemical Structure| 153559-49-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Bexarotene (LGD1069) is a high-affinity and selective retinoid X receptor (RXR) agonist with EC50s of 33, 24, and 25 nM for RXRα, RXRβ, and RXRγ, respectively. Bexarotene shows limited affinity for RAR receptors (EC50 >10000 nM) and is used for researching cutaneous T-cell lymphoma.

Synonyms: LGD1069; Ro 26-445; SR 11247

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Bexarotene

CAS No. :153559-49-0
Formula : C24H28O2
M.W : 348.48
SMILES Code : O=C(O)C1=CC=C(C(C2=C(C)C=C3C(C)(C)CCC(C)(C)C3=C2)=C)C=C1
Synonyms :
LGD1069; Ro 26-445; SR 11247
MDL No. :MFCD00932428
InChI Key :NAVMQTYZDKMPEU-UHFFFAOYSA-N
Pubchem ID :82146

Safety of Bexarotene

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00316030 AML|Acute Myeloid Leukemia PHASE1 COMPLETED - Abramson Cancer Center of Univ... More >>ersity of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States Less <<
NCT00718770 Thyroid Cancer EARLY_PHASE1 COMPLETED 2025-02-13 University of Colorado Cancer ... More >>Center, Aurora, Colorado, 80045, United States Less <<
NCT00002212 Sarcoma, Kaposi|HIV Infections PHASE2 COMPLETED - Desert Univ School of Medicine... More >>, Palm Springs, California, 92262, United States|Tulane Univ School of Medicine, New Orleans, Louisiana, 70112, United States|Milton S Hershey Med Ctr, Hershey, Pennsylvania, 17033, United States Less <<
NCT01007448 Refractory Cutaneous T-cell Ly... More >>mphoma Less << PHASE4 COMPLETED 2014-02-20 University of Alabama at Birmi... More >>ngham, Birmingham, Alabama, 35233, United States|Florida Academic Dermatology Centers, Miami, Florida, 33136, United States|Emory University, Atlanta, Georgia, 30322, United States|Rush University, Chicago, Illinois, 60612, United States|Tulane, New Orleans, Louisiana, 70112, United States|University of Michigan, Ann Arbor, Michigan, 48109, United States|University of Minnesota Medical School, Minneapolis, Minnesota, 55455, United States|Washington University, Saint Louis, Missouri, 63110, United States|University of Rochester, Rochester, New York, 14642, United States|Duke University, Durham, North Carolina, 27710, United States|Wake Forest University Health, Winston-Salem, North Carolina, 27157, United States|University Hospitals-Case Medical Center, Cleveland, Ohio, 44106, United States|University of Pittsburgh, Pittsburgh, Pennsylvania, 15213, United States|Vanderbilt, Nashville, Tennessee, 37206, United States|University of Texas Southwestern Medical Center, Dallas, Texas, 75390, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States|Huntsman Cancer Institute At the University of Utah, Salt Lake City, Utah, 84112, United States Less <<
NCT00615784 Acute Myeloid Leukemia PHASE2 TERMINATED 2013-11-08 Abramson Cancer Center of Univ... More >>ersity of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States Less <<
NCT00845351 Cushing's Disease PHASE1|PHASE2 UNKNOWN 2025-12-11 University of Virginia, Charlo... More >>ttesville, Virginia, 22908, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.87mL

0.57mL

0.29mL

14.35mL

2.87mL

1.43mL

28.70mL

5.74mL

2.87mL

References

 

Historical Records

Categories